Christina H Ruhlmann - Department of Oncology, Odense University Hospital

基本信息

浏览量：66

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 52 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Organ-specific Accuracy of [18F]FDG-PET/CT in Identifying Immune-Related Adverse Events in Patients with High-Risk Melanoma Treated with Adjuvant Immune Checkpoint Inhibitor

Birte Molvik Gideonse, Magnus Birkeland,Mie Holm Vilstrup,Peter Grupe,Mohammad Naghavi-Behzad,Christina H. Ruhlmann,Oke Gerke,Malene Grubbe Hildebrandt

Japanese Journal of Radiologypp.1-12, (2024)

引用0浏览0WOS引用

Does Patient Sex Affect the Treatment Outcome of Immune Checkpoint Inhibitors? A Danish Observational Melanoma Study

Soeren Kjaer Petersen,Christian Ronn Hansen,Eva Ellebaek,Henrik Schmidt,Charlotte Aaquist Haslund,Christina H. Ruhlmann,Lars Bastholt

EUROPEAN JOURNAL OF CANCER（2024）

引用0浏览0WOS引用

2023 Updated MASCC/ESMO Consensus Recommendations: Controlling Nausea and Vomiting with Chemotherapy of Low or Minimal Emetic Potential

Ian Olver,Rebecca Clark-Snow,Christina H. Ruhlmann, Maria-Angeles Garcia-del-Barrio,Lee Schwartzberg,Bernardo Leon Rapoport,Franziska Jahn

SUPPORTIVE CARE IN CANCERno. 1 (2024)

引用0浏览0WOS引用

Rebecca Schou Jurlander, Louise Mahncke Guldbrandt, Rikke B. Holmstroem, Kasper Madsen,Marco Donia,Charlotte A. Haslund, Henrik Schmidt,Lars Bastholt,Christina H. Ruhlmann,Inge Marie Svane,Eva Ellebaek

EUROPEAN JOURNAL OF CANCER (2024)

引用0浏览0WOS引用

Value of 2-[ 18 F]FDG-PET/CT in Identifying Immune-Related Adverse Events in Patients with Melanoma or Non-Small Cell Lung Cancer: a Systematic Scoping Review

Sambavy Nadaraja, Jonas Helsing, Mohammad Naghavi-Bezhad,Lotte H. Land,Christina H. Ruhlmann,Oke Gerke,Malene G. Hildebrandt

Clinical and translational imaging/Clinical and Translational Imagingno. 2 (2024): 187-195

引用0浏览0引用

Value of 2-[¹⁸F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review

Sambavy Nadaraja, Jonas Helsing, Mohammad Naghavi-Bezhad,Lotte H. Land,Christina H. Ruhlmann,Oke Gerke,Malene G. Hildebrandt

CLINICAL AND TRANSLATIONAL IMAGINGno. 2 (2024): 187-195

引用0浏览0引用

Frequency and Characteristics of Immune-Related Thyroid Adverse Events in Patients with Resected Stage III/IV Melanoma Treated with Adjuvant PD-1 Inhibitors: a National Cohort Study

Stine K. Christensen, Mette L. Winther, Ida J. Laursen,Freja S. Madsen,Carsten Brink,Thomas H. Brix,Eva Ellebaek,Inge Marie Svane, Frederikke S. Hansen,Charlotte Haslund,Olivia K. Laursen,Henrik Schmidt, Ida D. Larsen,Lars Bastholt,Christina H. Ruhlmann

SUPPORTIVE CARE IN CANCERno. 5 (2024)

引用0浏览0WOS引用

1109P Association of Clinical Features with Long-Term Survival in Patients with Melanoma Who Responded to Distinct Checkpoint Inhibitors

E. Ellebaek, S. Khan,T.H. Borch, L.M. Guldbrandt, R.B. Friis, H. Schmidt, A.A. Luczak,C.H. Ruhlmann, L. Bastholt,I.M. Svane,M. Donia

Annals of Oncology (2024)

引用0浏览0引用

Emetic Risk Classification and Evaluation of the Emetogenicity of Antineoplastic Agents—updated MASCC/ESMO Consensus Recommendation

Karin Jordan,Alexandre Chan,Richard J. Gralla,Franziska Jahn,Bernardo Rapoport,Christina H. Ruhlmann, Paula Sayegh,Paul J. Hesketh

SUPPORTIVE CARE IN CANCERno. 1 (2024)

引用0浏览0WOS引用

2023 Updated MASCC/ESMO Consensus Recommendations: Prevention of Radiotherapy- and Chemoradiotherapy-Induced Nausea and Vomiting

Christina H. Ruhlmann,Karin Jordan,Franziska Jahn,Ernesto Maranzano,Alex Molassiotis,Kristopher Dennis

ESMO OPENno. 2 (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn